C1GALT1
Basic information
Region (hg38): 7:7156934-7248616
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the C1GALT1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 21 | 23 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 21 | 2 | 1 |
Variants in C1GALT1
This is a list of pathogenic ClinVar variants found in the C1GALT1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
7-7234372-T-C | not specified | Uncertain significance (Feb 15, 2023) | ||
7-7234380-C-A | not specified | Uncertain significance (Jul 14, 2022) | ||
7-7234423-T-G | Benign (Apr 10, 2018) | |||
7-7234438-A-G | not specified | Uncertain significance (Jun 10, 2022) | ||
7-7234495-T-C | not specified | Uncertain significance (Apr 20, 2024) | ||
7-7238347-A-C | not specified | Uncertain significance (Sep 06, 2023) | ||
7-7238362-A-G | not specified | Uncertain significance (Jul 15, 2021) | ||
7-7238375-G-A | not specified | Uncertain significance (Sep 22, 2023) | ||
7-7238375-G-T | not specified | Uncertain significance (May 18, 2022) | ||
7-7238385-A-C | not specified | Uncertain significance (Sep 22, 2022) | ||
7-7238431-G-A | not specified | Uncertain significance (Jan 19, 2022) | ||
7-7238441-C-G | not specified | Uncertain significance (Dec 27, 2023) | ||
7-7238500-G-C | not specified | Uncertain significance (Jan 29, 2024) | ||
7-7238549-C-T | not specified | Uncertain significance (Oct 26, 2021) | ||
7-7238561-T-C | not specified | Uncertain significance (Apr 18, 2023) | ||
7-7238738-G-A | not specified | Uncertain significance (Nov 21, 2023) | ||
7-7238747-T-C | not specified | Uncertain significance (Aug 22, 2023) | ||
7-7238761-C-T | Likely benign (Apr 10, 2018) | |||
7-7238785-A-G | not specified | Uncertain significance (Oct 25, 2023) | ||
7-7238816-T-C | not specified | Likely benign (Oct 18, 2021) | ||
7-7238853-C-G | not specified | Uncertain significance (Jul 26, 2022) | ||
7-7238875-C-T | not specified | Uncertain significance (Apr 10, 2023) | ||
7-7243653-C-G | not specified | Uncertain significance (Jun 06, 2023) | ||
7-7243660-G-A | not specified | Uncertain significance (Nov 17, 2022) | ||
7-7243704-A-G | not specified | Uncertain significance (Jul 12, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
C1GALT1 | protein_coding | protein_coding | ENST00000436587 | 3 | 91718 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.763 | 0.237 | 125728 | 0 | 7 | 125735 | 0.0000278 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.118 | 184 | 189 | 0.976 | 0.00000913 | 2401 |
Missense in Polyphen | 15 | 49.712 | 0.30174 | 685 | ||
Synonymous | -1.16 | 79 | 66.9 | 1.18 | 0.00000343 | 652 |
Loss of Function | 2.90 | 2 | 13.5 | 0.148 | 5.66e-7 | 196 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000579 | 0.0000579 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000448 | 0.0000440 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Glycosyltransferase that generates the core 1 O-glycan Gal-beta1-3GalNAc-alpha1-Ser/Thr (T antigen), which is a precursor for many extended O-glycans in glycoproteins. Plays a central role in many processes, such as angiogenesis, thrombopoiesis and kidney homeostasis development.;
- Pathway
- Mucin type O-glycan biosynthesis - Homo sapiens (human);Ectoderm Differentiation;Post-translational protein modification;Metabolism of proteins;mucin core 1 and core 2 <i>O</i>-glycosylation;O-linked glycosylation of mucins;O-linked glycosylation
(Consensus)
Recessive Scores
- pRec
- 0.188
Intolerance Scores
- loftool
- 0.185
- rvis_EVS
- 0.08
- rvis_percentile_EVS
- 60.09
Haploinsufficiency Scores
- pHI
- 0.177
- hipred
- N
- hipred_score
- 0.452
- ghis
- 0.506
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- essential_gene_gene_trap
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.867
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- C1galt1
- Phenotype
- growth/size/body region phenotype; endocrine/exocrine gland phenotype; cellular phenotype; homeostasis/metabolism phenotype; renal/urinary system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); neoplasm; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); digestive/alimentary phenotype; immune system phenotype;
Gene ontology
- Biological process
- angiogenesis;kidney development;O-glycan processing, core 1;intestinal epithelial cell development
- Cellular component
- Golgi membrane;integral component of membrane
- Molecular function
- protein binding;glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity;metal ion binding